A comparison of fluconazole with ketoconazole, itraconazole, and clotrimazole in the treatment of patients with pityriasis versicolor

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 4, 1998, Pages 203-214

  Silva, Honorio ^a   Gibbs, David ^a   Arguedas, Jorge ^a  

^a PFIZER INC   (United States)

Author keywords

Antifungal agents; Fluconazole; Tinea versicolor; Weekly therapy

Indexed keywords

CLOTRIMAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALASSEZIA FURFUR; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REINFECTION; TINEA VERSICOLOR; TOPICAL DRUG ADMINISTRATION;

EID: 0031956596     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85073-X     Document Type: Article

References (24)

1. Savin R. Diagnosis and treatment of tinea versicolor. J Fam Pract. 1996;3:127-132.
2. Borelli D, Jacobs PH, Nall L. Tinea versicolor: Epidemiologic, clinical, and therapeutic aspects. J Am Acad Dermatol. 1991;25:300-305.
3. Silva-Lizama E. Tinea versicolor. Int J Dermatol. 1995;34:611-617.
4. Faergemann J. Pityrosporum ovale and skin disease. Keio J Med. 1993;42:91-94.
5. Roberts SOB. Pityrosporum orbiculare: Incidence and distribution on clinically normal skin. Br J Dermatol. 1969;81:264-269.
6. Dominguez-Soto L, Hojyo-Tomoka T, Vega-Memije E, et al. Pigmentary problems in the tropics. Dermatol Clin. 1994;12:777-784.
7. Shrum JP, Millikan LE, Bataineh O. Superficial fungal infections in the tropics. Dermatol Clin. 1994;12:687-693.
8. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines for care of superficial mycotic infections of the skin: Pityriasis (tinea) versicolor. J Am Acad Dermatol. 1996;34:287-289.
9. Jacobs PH. Treatment of fungal skin infections: State of the art. J Am Acad Dermatol. 1990;23:549-551.
10. Goodless DR, Ramos-Caro FA, Flowers FP. Ketoconazole in the treatment of pityriasis versicolor: International review of clinical trials. DICP. 1991;25:395-398.
11. Faergemann J, Djarv L. Tinea versicolor: Treatment and prophylaxis with ketoconazole. Cutis. 1982;30:542-545, 550.
12. Faergemann J. Treatment of pityriasis versicolor with itraconazole: A double-blind placebo controlled study. Mycoses. 1988;31:377-379.
13. Hickman JG. A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor. J Am Acad Dermatol. 1996;34(5 pt 1):785-787.
14. Delescluse J. Itraconazole in tinea versicolor: A review. J Am Acad Dermatol. 1990;23: 551-554.
15. Faergemann J. Treatment of pityriasis versicolor with a single dose of fluconazole. Acta Derm Venereol (Stockh). 1992;72:74-75.
16. Amer MA and the Egyptian Fluconazole Study Group. Fluconazole in the treatment of tinea versicolor. Int J Dermatol. 1997;38:940-942.
17. Faergemann J. Activity of triazole derivatives against Pityrosporum obiculare in vitro and in vivo. Ann NY Acad Sci. 1988;544:348-353.
18. Saag MS, Dismukes WE. Azole antifungal agents: Emphasis on the new triazoles. Antimicrob Agents Chemother. 1988;32:1-8.
19. Hay RJ. Risk/benefit ratio of modern antifungal therapy: Focus on hepatic reactions. J Am Acad Dermatol. 1993;29:S50-S54.
20. Borelli D. Treatment of pityriasis versicolor with ketoconazole. Rev Infect Dis. 1980;2: 592-595.
21. Montes LF, Oakes RA, Pert P, et al. Topical griseofulvin in tinea versicolor: A doubleblind study. J Am Acad Dermatol. 1991;25:726-728.
22. Brammer KW, Farrow PR, Faulkner JK. Pharmacokinetic and tissue penetration of fluconazole in humans. Rev Infect Dis. 1990;12(Suppl 3):S318-S326.
23. Haneke E. Fluconazole levels in human epidermis and blister fluid. Br J Dermatol. 1990;123:273-274.
24. Faergemann J, Laufen H. Levels of fluconazole in serum, stratum corneum, epidermis (without stratum corneum) and eccrine sweat. Clin Exp Dermatol. 1993;18:102-106.